Manning & Napier Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104M | Sell |
233,580
-1,528
| -0.6% | -$680K | 1.24% | 29 |
|
|
2025
Q1 | $114M | Buy |
235,108
+84,982
| +57% | +$41.2M | 1.41% | 22 |
|
|
2024
Q4 | $60.5M | Sell |
150,126
-5,635
| -4% | -$2.27M | 0.69% | 45 |
|
|
2024
Q3 | $72.4M | Sell |
155,761
-2,571
| -2% | -$1.2M | 0.8% | 37 |
|
|
2024
Q2 | $74.2M | Buy |
+158,332
| New | +$74.2M | 0.84% | 42 |
|
|
2017
Q3 | $135M | Sell |
885,868
-745,258
| -46% | -$113M | 1.15% | 32 |
|
|
2017
Q2 | $210M | Sell |
1,631,126
-133,293
| -8% | -$17.2M | 1.81% | 16 |
|
|
2017
Q1 | $193M | Sell |
1,764,419
-361,601
| -17% | -$39.5M | 1.5% | 23 |
|
|
2016
Q4 | $157M | Buy |
2,126,020
+1,983,480
| +1,392% | +$146M | 1.02% | 39 |
|
|
2016
Q3 | $12.4M | Buy |
142,540
+15,550
| +12% | +$1.36M | 0.08% | 98 |
|
|
2016
Q2 | $10.9M | Buy |
+126,990
| New | +$10.9M | 0.07% | 111 |
|